Journal Article Summary
The article investigates the outcomes of two long-acting reversible contraceptive methods: subdermal implants and levonorgestrel intrauterine systems (LNG-IUS) in women of reproductive age. This topic is significant as it addresses the growing need for effective contraceptive options and the potential side effects associated with these methods. With nearly 900 million women globally using modern contraceptives, understanding the differences in satisfaction and side effects between these two popular methods can help women make informed choices about their reproductive health.
The researchers conducted a systematic review and meta-analysis of six randomized controlled trials involving 1,503 women. They found that those using subdermal implants reported higher rates of dissatisfaction, acne, weight gain, and device removal due to side effects compared to those using LNG-IUS. While both methods were effective for contraception, the study highlighted that subdermal implants might lead to more adverse experiences, particularly in terms of physical changes and overall satisfaction.
However, the study has limitations, including a small number of trials directly comparing the two methods and a lack of standardized assessments for bleeding and side effects. Additionally, the findings may not apply to younger populations, as the included studies did not involve adolescents. Patients should discuss these findings with their healthcare professionals, considering their individual health needs and preferences when choosing a contraceptive method. Understanding the potential side effects and satisfaction levels associated with each option can aid in making a more personalized decision.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Oliveira Juliana Almeida, Neves Gabriel Lage, Pinhati Matheus Eduardo Soares, de Oliveira Flávia Ribeiro, Filho Agnaldo Lopes da Silva. Subdermal implants vs. levonorgestrel intrauterine devices outcomes in reproductive-aged women: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics 2025. DOI: 10.1007/s00404-025-07943-6. PMID: 40069520. PMCID: PMC11985546.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
